PEG-MGF
Pegylated Mechano Growth Factor
PEG-MGF is a muscle-growth peptide followed by performance communities, but it stays outside lawful routine compounding.
Current status
Restricted
Muscle-related interest, with current federal compounding constraints still in play.
FDA category
Category 2
Can pharmacies compound this?
No
Reclassification expected?
Unclear
Little formal momentum exists compared with the more mainstream peptides.
Primary Use
Muscle-related interest
Regulatory Timeline
Feb 27, 2026
Political pressure and market expectations increased around a future peptide reclassification review.
Sep 29, 2023
Current status signal recorded: Performance-focused peptide remains restricted..
Mar 15, 2023
FDA peptide compounding scrutiny intensified across 503A and 503B channels.
Get notified...
Get notified when PEG-MGF status changes
State-specific notes
Ohio
Compounding boards tend to treat it as high risk.